Contrast Media Market revenue to cross USD 13 Billion by 2035, says Research Nester
November 07, 2023 06:00 ET
|
Research Nester
New York , Nov. 07, 2023 (GLOBE NEWSWIRE) -- The global contrast media market size is predicted to expand at 6.70% CAGR between 2023 and 2035. The market is projected to garner a revenue of USD 13...
PaxMedica Engages Bourne Partners to Explore Future Monetization of Potential Priority Review Voucher (PRV)
November 02, 2023 08:30 ET
|
PaxMedica, Inc.
TARRYTOWN, N.Y., Nov. 02, 2023 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (Nasdaq: PXMD), a pioneering biopharmaceutical company focused on advancing treatments for neurologic disorders, has...
Groundbreaking study reveals link between air pollution and incidence of Parkinson’s disease
October 31, 2023 18:07 ET
|
Barrow Neurological Institute at Dignity Health St. Joseph's Hospital and Medical Center
Phoenix, Oct. 31, 2023 (GLOBE NEWSWIRE) -- A new study led by researchers at Barrow Neurological Institute has found that people living in regions with median levels of air pollution have a 56...
Allyx Therapeutics Lead Compound ALX-001 is Safe and Tolerable at Doses, Achieving Full Brain Target Engagement in Healthy Older Adults
October 30, 2023 08:30 ET
|
Allyx Therapeutics Inc.
Allyx Therapeutics Phase 1a Clinical Data Presented at Clinical Trials on Alzheimer's Disease Meeting Support Continued Clinical Development
Catalyst Pharmaceuticals Partners with Sofie's Journey to Bring Focus on Epilepsy at the 11th Annual Epilepsy Awareness and Education Expo
October 30, 2023 08:03 ET
|
Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing,...
Embolization Coils Market revenue to cross USD 3 Billion by 2035, says Research Nester
October 26, 2023 06:30 ET
|
Research Nester
New York , Oct. 26, 2023 (GLOBE NEWSWIRE) -- The global embolization coils market size is estimated to attain at 6% CAGR from 2023 to 2035. The market is expected to garner a revenue of USD 3...
Alzheimer’s Leaders Discuss How to Shift Science into Clinical Practice During National Alzheimer’s Summit
October 20, 2023 12:58 ET
|
UsAgainstAlzheimer's
Washington, DC, Oct. 20, 2023 (GLOBE NEWSWIRE) -- UsAgainstAlzheimer’s this week hosted the 2023 National Alzheimer’s Summit, a groundbreaking event dedicated to applying recent scientific and...
Allyx Therapeutics to Present Phase 1 Data for Lead Compound ALX-001 at the 16th Clinical Trials on Alzheimer's Disease Meeting
October 19, 2023 16:05 ET
|
Allyx Therapeutics Inc.
Allyx Therapeutics presents Phase 1 ALX-001 data at CTAD. ALX-001 is a small molecule with unique mechanism at mGluR5 to protect and preserve synapses.
Neurovascular Devices Market - Global Forecast to 2028: Increasing Incidence of Ischemic Stroke and Cerebral Aneurysms Boosts Demand
October 18, 2023 05:48 ET
|
Research and Markets
Dublin, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The "Neurovascular Devices Market by Disease Pathology (Cerebral Ameurysm (Embolic coils), Ischemic Stroke (Clot retrievers, Aspiration, Microcatheters),...
Sosei Heptares and PharmEnable Therapeutics Expand Drug Discovery Collaboration
October 10, 2023 02:30 ET
|
Sosei Group Corporation
The collaboration combines Sosei Heptares’ leading structure-based drug design platform with PharmEnable’s advanced artificial intelligence-enabled platform for designing high quality novel chemistry...